trish, over to you. >> mike huckman, thank you for that.ootball fans continue to count down to the game and low ticket prices could make this the cheapest super bowl in years. darren rovell breaks it all down for us live from sun life stadium in miami, garden florida and daeren, can you get me a deal on the ticket? >> deal is all relative. cheap, trish, is all relative, but as of this morning, stub hub is telling us that the average ticket price is 2,520. that's actually lower than a lot of other games and it might stay low because obviously the winter storm might be corporate america can't get down here and others say saints fans can still drive to miami. as of now, fans of the saints who have never been to the super bowl are outnumbering buyers from the colt's native region. >> we've seen about a four to one difference. right now 27% of the buyers are from louisiana compared to about six, serve from indiana and mixed in there is 11% in florida and new york, new jersey, california trickle in. >> yeah, this game is clearly about corporate a

. >>> when we come back, the ceo of roche sits down with our pharmaceutical reporter mike huckman abouthe pipeline for the drugmaker. >>> and the jobs number only an hour away as "squawk box" continues. >>> as we head to the break, here's a look at the widely held stocks. "squawk box" returns after this. national car rental knows i'm picky. so, at national, i go right past the counter... and you get to choose any car in the aisle. choose any car? you cannot be serious! okay. seriously, you choose. go national. go like a pro. >>> sales of the world's most widely used cancer drug, avastin, jumped 21% last year, but that was not enough apparently to satisfy investors in the swiss drug giant roche, the stock has been down since the company reported results. that's pretty telling, that's the sign of a weak market. cnbc's pharmaceuticals reporter and author of the pharma's market widely read blog, his name is mike huckman and he's in new york and it's another "squawk" exclusive. good morning, mike. >> good morning, joe. when he sat down with roche, they wanted to buy the remainder of genentec

in the meantime i'm mike huckman cnbc pharmaceuticals reporter with breaking news on dow component andhe world's biggest drug company pfizer. the company confirming for cnbc that the food and drug administration has approved its new and improved vaccine for pneumonia called prevnar 13. this was one of the most key products pfizer got in its recent purchase of wyath and covers more strains of pneumonia than the previous vaccine. it is a multibillion dollar product. analysts think this one is going to be as well and in addition to it being approved for infants and children as old as 5 the company plans to seek fda approval sometime this year of the same vaccine for adults which analysts think could add hundreds of millions, maybe even more than a billion dollars in revenue for this product. the fda according to pfizer has approved a new and improved pneumonia vaccine, a key new product for the world's biggest drug company. back to capitol hill. >> i want to talk now about the central question of employment. getting people back to work is important, socially most of all but also for the o